跳至主要内容
临床试验/CTRI/2026/04/107829
CTRI/2026/04/107829尚未招募Phase 3 4

A Randomized Controlled Clinical Trial To Evaluate The Efficacy Of Papaya-nimba Ksharsutra In The Management Of Bhagandara W.S.R.Fistula In Ano

Dr Vaishnavi Manohar Nagpure1 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2026年4月17日最近更新:

试验速览

阶段
Phase 3 4
状态
尚未招募
发起方
入组人数
120
试验地点
1

研究概览

简要总结

Title -“A Randomized Controlled Clinical Trial To Evaluate The Efficacy Of Papaya-Nimba Ksharsutra In The Management Of Bhagandara W.S.R Fistula in Ano ”

Type of Study Design: - Randomized Controlled Clinical Trial

Primary objective To evaluate the effectiveness of papaya- nimbaksharsutra in the management of bhagandara W.S.R Fistula in ano in comparison with standard snuhi-apamarga ksharsutra

Secondary objective

1)To propose an alternative easily available medicated ksharsutra in the management of bhagandara

2)To evaluate the pain and discomfort during and after procedure between the two groups

3)To evaluate the effect of papaya-nimbaksharsutra on wound healing time

4)To asscess the reduction in pain , discharge, and itching during treatment 7

A} Inclusion Criteria-

  1. Subjects having signs and symptoms of bhagandara W.S.R. Fistula in ano
  2. Simple low anal fistula
  3. Patients between the ages of 18 and 60
  4. Fistula Track Length Up to 5 cm
  5. Patient irrespective to gender ,cast religion, or economic status

B] EXCLUSION CRITERIA:

  1. Individuals with HIV and HBsAg positive
  2. Patients with uncontrolled diabetes and asthma  3. The development of fistula as a result of illnesses such as cancer, Crohn’s disease, IBD, ulcerative colitis, and tuberculosis
  3. Fistula with Multiple Tracks

研究设计

研究类型
Interventional
分配方式
Coin toss, Lottery, toss of dice, shuffling cards etc
盲法
Participant and Investigator Blinded

入排标准

年龄范围
18.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • Patients with signs and symptoms of bhagandara W.S.R. fistula in ano 2.simple low anal fistula 3.fistula tract length upto 5 cm 4.Patients irrespective to gender cast religion and economic status.

排除标准

  • 1.Indivisuals with HIV and HBSAG positive 2.Patients with uncontrolled DM and asthma
  • The development of fistula as a result of illness such as cancer crohns disease IBD ulcerative colitis tuberculosis 4.fistula with multiple tracts.

研究者

发起方
Dr Vaishnavi Manohar Nagpure
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr. Vaishnavi Manohar Nagpure

Vidarbha Ayurved Mahavidyalaya Amravati

研究点 (1)

Loading locations...

相似试验